Produktnummer:
18c61579cccc134b4aa38d48fc633dfa8b
| Themengebiete: | Antibody drug conjugates BCR-ABL Bruton's tyosine kinase Cancer drug research DNA damage response Epidermal growth factor receptor Epigentic modulators FGFR Kinases Vascular endothelial growth factor |
|---|---|
| Veröffentlichungsdatum: | 13.11.2018 |
| EAN: | 9783319759241 |
| Sprache: | Englisch |
| Seitenzahl: | 475 |
| Produktart: | Gebunden |
| Herausgeber: | Waring, Michael J. |
| Verlag: | Springer International Publishing |
Produktinformationen "Cancer II"
This book reviews recent breakthroughs in anti-cancer drug discovery. Building on the previous volume in the series, it outlines some of the most significant developments that have occurred in the field in the subsequent period that have led to new drug approvals or promising clinical candidates. The volume is divided into chapters that each relate to a specific protein or protein class. Each chapter provides an overview of the underlying biology and then emphasises the medicinal chemistry strategies and tactics that led to the most significant drugs and drug candidates. A summary of clinical data and the future outlook for the field is also provided. Each chapter is authored by experts in the topic and who have themselves made significant contributions to their respective fields.
Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen